Marvin Gee | VP, Target Discovery
3T Biosciences

Marvin Gee, VP, Target Discovery, 3T Biosciences

Marvin Gee is VP of Target Discovery and Co-Founder at 3T Biosciences, where he is responsible for leading target discovery and computation. He received his PhD in Immunology with an additional focus in Computational Immunology at Stanford University. He published his main work on novel technology to identify the specificities of T- cell receptors for applications in oncology and further work on characterizing the structural basis of T- cell receptor recognition of immunological targets and T cell receptor cross-reactivity. He has had prior work experience engineering T cell receptors for adoptive T cell therapy. Marvin has been featured in Forbes 30-under-30 in Healthcare.


Festival of Biologics Day 1 @ 14:20

High potency modalities for the treatment of solid tumors

last published: 29/Nov/23 17:45 GMT

back to speakers